Fluvastatin
Fluvastatin is a pharmaceutical drug with 29 clinical trials. Historical success rate of 88.0%.
Success Metrics
Based on 22 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
7
Mid Stage
17
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.5%
22 of 27 finished
18.5%
5 ended early
0
trials recruiting
29
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas
Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.
Effect of Fluvastatin on Brown Fat Activity
Clinical Trials (29)
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas
Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.
Effect of Fluvastatin on Brown Fat Activity
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients
Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer
Fluvastatin in Adults With Dislipidemia With History of Muscle Problems
Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome
Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers
Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome
Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant
High Potency Statins and Acute Kidney Injury
High Potency Statins and the Risk of Diabetes
The Role of the "Inflammatory/ Pathogen Burden" for Cardiac Ageing
A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C
Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin
Fluvastatin Versus Hepatitis C Virus
Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 29